Skip to main content
OpenTrials

Clinical trial condition

Nephrosis, Lipoid

Explore clinical trials studying Nephrosis, Lipoid. Study availability and eligibility vary by location and protocol.

58 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

Nephrosis, Lipoid trial results

Recruiting

A Trial to Assess the Efficacy and Safety of Obinutuzumab in Treating Adults With Minimal Change Disease (MCD)

NCT07710157

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +6 more
Locations
  • Division of Nephrology, Department of Internal Medicine, Medical University of Graz Graz, Austria
  • Department of Internal Medicine IV, Nephrology and Hypertension Innsbruck, Austria
  • 6. Medizinische Abteilung mit Nephrologie & Dialyse, Klinik Ottakring Vienna, Austria
  • Laboratory of Immunology, Nice University Hospital (CHU de Nice), Côte d'Azur University Nice, France
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

NCT06500702

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis, +10 more
Locations
  • Investigational Site Number : 8400007 Birmingham, Alabama, United States
  • Investigational Site Number : 8400015 Orange, California, United States
  • Investigational Site Number : 8400012 San Francisco, California, United States
  • Investigational Site Number : 8400025 Tampa, Florida, United States
View all 71 locations
View Trial Details
Recruiting

NEPTUNE Match Study

NCT04571658

Conditions
Alport Syndrome, Autoimmune Diseases, Collagen Diseases, +29 more
Locations
  • Emory University Hospital - Children's Hospital of Atlanta Atlanta, Georgia, United States
  • John H. Stroger, Jr., Hospital of Cook County Chicago, Illinois, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • Johns Hopkins Medicine Baltimore, Maryland, United States
View all 16 locations
View Trial Details
Recruiting

Nephrotic Syndrome Study Network

NCT01209000

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations
  • University of Southern California-Children's Hospital Los Angeles, California, United States
  • Stanford University School of Medicine Palo Alto, California, United States
  • University of California San Francisco Benioff Children's Hospitals San Francisco, California, United States
  • Lundquist Biomedical Research Institute at Harbor UCLA Medical Center Torrance, California, United States
View all 44 locations
View Trial Details
Recruiting

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

NCT05003986

Conditions
Alport Syndrome, Autoimmune Diseases, Blood Coagulation Disorders, +42 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Nemours Children's Hospital Wilmington, Delaware, United States
  • University of Miami, Leonard M. Miller School of Medicine Miami, Florida, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
View all 47 locations
View Trial Details
Recruiting

A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)

NCT05583942

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis, +11 more
Locations
  • Cohen Children's Medical Center New Hyde Park, New York, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

taVNS for FRNS in Children

NCT05588063

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis, +11 more
Locations
  • Cohen Children's Medical Center New Hyde Park, New York, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions